[HTML][HTML] Radiomics for precision medicine: Current challenges, future prospects, and the proposal of a new framework

A Ibrahim, S Primakov, M Beuque, HC Woodruff… - Methods, 2021 - Elsevier
The advancement of artificial intelligence concurrent with the development of medical
imaging techniques provided a unique opportunity to turn medical imaging from mostly …

Curcumin as an enhancer of therapeutic efficiency of chemotherapy drugs in breast cancer

R Farghadani, R Naidu - International Journal of Molecular Sciences, 2022 - mdpi.com
Female breast cancer is the world's most prevalent cancer in 2020. Chemotherapy still
remains a backbone in breast cancer therapy and is crucial in advanced and metastatic …

Breast cancer statistics, 2022

AN Giaquinto, H Sung, KD Miller… - CA: a cancer journal …, 2022 - Wiley Online Library
This article is the American Cancer Society's update on female breast cancer statistics in the
United States, including population‐based data on incidence, mortality, survival, and …

A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients

S Kuemmel, J Heil, A Rueland, C Seiberling… - Annals of …, 2022 - journals.lww.com
Objective: This study aimed to investigate the feasibility and accuracy of non-radioactive
TLN biopsy and TAD in routine clinical practice. Background Data: TAD involves TLN biopsy …

Breast cancer statistics, 2019

CE DeSantis, J Ma, MM Gaudet… - CA: a cancer journal …, 2019 - Wiley Online Library
This article is the American Cancer Society's biennial update on female breast cancer
statistics in the United States, including data on incidence, mortality, survival, and screening …

Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up

S Kahler-Ribeiro-Fontana, E Pagan, F Magnoni… - European Journal of …, 2021 - Elsevier
Introduction In patients with positive lymph nodes (cN+) prior to neoadjuvant treatment
(NAT), which convert to a clinically negative axilla (cN0) after treatment, the use of sentinel …

[HTML][HTML] Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges

J Heil, HM Kuerer, A Pfob, G Rauch, HP Sinn… - Annals of …, 2020 - Elsevier
Highlights•Safe past de-escalation treatments.•Surgery after complete response might be
overtreatment.•Biopsies might diagnose response.In patients with operable early breast …

The landmark series: neoadjuvant chemotherapy for triple-negative and HER2-positive breast cancer

RA Leon-Ferre, TJ Hieken, JC Boughey - Annals of surgical oncology, 2021 - Springer
While historically breast cancer has been treated with primary surgery followed by adjuvant
therapy, the delivery of systemic therapy in the neoadjuvant setting has become increasingly …

Adolescents and young adults with breast cancer have more aggressive disease and treatment than patients in their forties

BL Murphy, CN Day, TL Hoskin, EB Habermann… - Annals of surgical …, 2019 - Springer
Background Adolescents and young adults (AYAs; age< 40 years) account for less than 2%
of breast cancer patients. Therefore, little is known about the tumor characteristics and care …

[HTML][HTML] Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic treatment by an intelligent vacuum-assisted …

A Pfob, C Sidey-Gibbons, HB Lee, MK Tasoulis… - European Journal of …, 2021 - Elsevier
Background Neoadjuvant systemic treatment elicits a pathologic complete response (pCR)
in about 35% of women with breast cancer. In such cases, breast surgery may be …